This inventor holds 1 USPTO granted patent. Top assignee: Humboldt-Universitaet Zu Berlin. Active years: 1989.
Company Filing History:
Years Active: 1989
Title: Renate Grupe: Innovator in Pharmaceutical Chemistry
Introduction
Renate Grupe is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with valuable pharmacological properties. His work focuses on creating innovative solutions for various medical conditions.
Latest Patents
Renate Grupe holds a patent for a novel compound titled "1-(2-hydroxyaryl)-alkane-1-on-oximes-procedure of preparation and use." This patent outlines a procedure for preparing new 1-(2-hydroxylaryl)-alkane-1-on-oximes and their applicability in pharmaceutical preparations. The primary aim of this invention is to develop compounds with desirable pharmacological properties. The new compounds are characterized by their anti-asthmatic, anti-anaphylactic, antiphlogistic, antihypertensive, spasmolytic, antirheumatic, and antithrombotic potentials. They are applicable in both human and veterinary medicine for the treatment of asthma bronchiale, allergic diseases, inflammatory and rheumatic diseases, and thrombosis.
Career Highlights
Renate Grupe is affiliated with Humboldt-Universität zu Berlin, where he continues to advance his research in pharmaceutical chemistry. His work has led to significant advancements in the development of therapeutic agents that can improve patient outcomes.
Collaborations
Renate has collaborated with notable colleagues, including Juergen Slapke and Samuel M. Rapoport. These collaborations have further enriched his research and contributed to the success of his innovative projects.
Conclusion
Renate Grupe's contributions to pharmaceutical chemistry exemplify the impact of innovation in medicine. His patented work on 1-(2-hydroxyaryl)-alkane-1-on-oximes showcases his commitment to developing effective treatments for various health conditions.